Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Losi, F. Luppi, M. Luppi, B. M. Bergamini, M. Codeluppi, R. D‘Amico, C. Del Giovane, P. Roversi, F. Rumpianesi, M. Meacci, G. Torelli, L. Fabbri, L. Richeldi (Modena, Italy). Short-term reproducibility of the QuantiFERON-TB gold in-tube assay. Eur Respir J 2009; 34: Suppl. 53, 1693

Member's Comments

No comment yet.

Related content which might interest you: Using QuantiFERON-TB gold in-tube in contact tracing procedures Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Programmatic experience with QuantiFERON-TB gold in-tube assay for contact screening in congregate settings in Singapore Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 QuantiFERON-TB gold in tube method in sarcoidosis patients Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 First evaluation of QuantiFERON-TB Gold Plus performance in contact screening Source: Eur Respir J 2016; 48: 1411-1419 Year: 2016 Preliminary data on precision of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 48: 955-956 Year: 2016 Preliminary data on precision of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 48: 953-954 Year: 2016 Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 First independent evaluation of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 47:1587-1590 Year: 2016 Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection Source: Eur Respir J 2013; 41: 909-916 Year: 2013 Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Use of QuantiFERON-TB gold test in diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 140s Year: 2006 QuantiFERON-TB® Gold Plus as a potential tuberculosis treatment monitoring tool Source: Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016 Year: 2017 The QuantiFERON-TB Gold test at HIV patients Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Evaluation of usefulness of QuantiFERON®-TB Gold for infants Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 A comparison of QuantiFERON-TB Gold In-Tube test and new QuantiFERON-Microtube assay in children suspect of active TB and adults with active TB Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Comparison of QuantiFERON-TB Gold test and tuberculin skin test in diagnosis of pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 133s Year: 2007 Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test: need for a further step? Source: Eur Respir J 2015; 46: 1506-1509 Year: 2015 Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test Source: Eur Respir Rev 2008; 17: 74-75 Year: 2008 Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold in tube test Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016